{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:50:50Z","timestamp":1768809050822,"version":"3.49.0"},"reference-count":36,"publisher":"Pan American Health Organization","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,16]]},"DOI":"10.26633\/rpsp.2024.104","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T11:43:38Z","timestamp":1734349418000},"page":"1","source":"Crossref","is-referenced-by-count":1,"title":["Molecular epidemiology of rubella during the pre- and post-elimination eras in the Americas"],"prefix":"10.26633","volume":"48","author":[{"given":"Min-hsin","family":"Chen","sequence":"first","affiliation":[{"name":"Viral Vaccine Preventable Diseases Branch, National Center for Immunization & Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, United States of America."},{"name":"zvp8@cdc.gov"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Suzanne","family":"Beard","sequence":"additional","affiliation":[{"name":"Viral Vaccine Preventable Diseases Branch, National Center for Immunization & Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, United States of America."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Hiebert","sequence":"additional","affiliation":[{"name":"Viral Diseases Division, National Microbiology Laboratory Branch, Public Health Agency of Canada, JC Wilt Infectious Diseases Research Centre, Winnipeg, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Rey-Benito","sequence":"additional","affiliation":[{"name":"Pan American Health Organization\/World Health Organization, Washington, DC, United States of America."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11167","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Winter AK, Moss WJ. Rubella. Lancet. 2022;399(10332):1336-46.","DOI":"10.1016\/S0140-6736(21)02691-X"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Abernathy E, Peairs RR, Chen M-h, Icenogle J, Namdari H. Genomic characterization of a persistent rubella virus from a case of Fuch\u2019 uveitis syndrome in a 73 year old man. J Clin Virol. 2015;69:104-9.","DOI":"10.1016\/j.jcv.2015.06.084"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Doan T, Wilson MR, Crawford ED, Chow ED, Khan LM, Knopp KA, et al. Illuminating uveitis: metagenomic deep sequencing identifies common and rare pathogens. Genome Med. 2016;8(1):90.","DOI":"10.1186\/s13073-016-0377-x"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Murguia-Favela L, Hiebert J, Haber RM. \u201cNoninfectious\u201d cutaneous granulomas in primary immunodeficiency patients and association with rubella virus vaccine strain. J Cutan Med Surg. 2019;23(3):341-2.","DOI":"10.1177\/1203475419825780"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Shields BE, Perelygina L, Samimi S, Haun P, Leung T, Abernathy E, et al. Granulomatous dermatitis associated with rubella virus infection in an adult with immunodeficiency. JAMA Dermatol. 2021;157(7):842-7.","DOI":"10.1001\/jamadermatol.2021.1577"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Perelygina L, Chen MH, Suppiah S, Adebayo A, Abernathy E, Dorsey M, et al. Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies. PLoS Pathog. 2019;15(10):e1008080.","DOI":"10.1371\/journal.ppat.1008080"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Kanai M, Kamiya H, Okuno H, Sunagawa T, Tanaka-Taya K, Matsui T, et al. epidemiology of congenital rubella syndrome related to the 2012-2013 rubella epidemic in Japan. J Pediatric Infect Dis Soc. 2022;11(9):400-3.","DOI":"10.1093\/jpids\/piac043"},{"key":"ref8","unstructured":"Pan American Health Organization. Americas Region is declared the world\u2019s first to eliminate rubella 2015. [Accessed 20 March 2024]. Available from: https:\/\/www.paho.org\/en\/news\/29-4-2015-americas-region-declared-worlds-first-eliminate-rubella"},{"key":"ref9","unstructured":"Pan American Health Organization. Regional Framework for the Monitoring and Re-Verification of Measles, Rubella, and Congenital Rubella Syndrome Elimination in the Americas. 2022. [Accessed 20 March 2024]. Available from: https:\/\/iris.paho.org\/handle\/10665.2\/55074."},{"key":"ref10","unstructured":"Pan American Health Organization. Immunization Newsletter. 2003;45(1). [Accessed 20 March 2024]. Available from: https:\/\/iris.paho.org\/handle\/10665.2\/57594"},{"key":"ref11","unstructured":"World Health Organization. Global vaccine action plan 2011-2020 [Accessed 20 March 2024]. Available from: https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/strategies\/global-vaccine-action-plan"},{"key":"ref12","unstructured":"World Health Organization. Rubella virus nomenclature update: 2013. Wkly Epidemiol Rec. 2013;88(32):337-43."},{"key":"ref13","unstructured":"World Health Organization. Standardization of the nomenclature for genetic characteristics of wild-type rubella viruses. Wkly Epidemiol Rec. 2005;80(14):126-32."},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Frey TK, Abernathy ES, Bosma TJ, Starkey WG, Corbett KM, Best JM, et al. molecular analysis of rubella virus epidemiology across three continents, North America, Europe, and Asia, 1961\u20131997. J Infect Dis. 1998;178(3):642-50.","DOI":"10.1086\/515370"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Rivailler P, Abernathy E, Icenogle J. Genetic diversity of currently circulating rubella viruses: a need to define more precise viral groups. J Gen Virol. 2017;98(3):396-404.","DOI":"10.1099\/jgv.0.000680"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Brown KE, Rota PA, Goodson JL, Williams D, Abernathy E, Takeda M, Mulders MN. Genetic characterization of measles and rubella viruses detected through global measles and rubella elimination surveillance, 2016-2018. MMWR Morb Mortal Wkly Rep. 2019;68(26):587-91.","DOI":"10.15585\/mmwr.mm6826a3"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Icenogle JP, Siqueira MM, Abernathy ES, Lemos XR, Fasce RA, Torres G, Reef SE. Virologic surveillance for wild-type rubella viruses in the Americas. J Infect Dis. 2011;204(Suppl 2):S647-51.","DOI":"10.1093\/infdis\/jir431"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Reef SE, Icenogle JP, Plotkin SA. The path to eradication of rubella. Vaccine. 2023;41(50):7525-31.","DOI":"10.1016\/j.vaccine.2023.11.014"},{"key":"ref19","unstructured":"US National Center for Immunization and Respiratory Diseases. Manual for the Surveillance of Vaccine-Preventable Diseases: Centers for Disease Control and Prevention, Department of Health and Human Services. Updated 6 March 6 2020. [Accessed 20 March 2024]. Available from: https:\/\/www.cdc.gov\/vaccines\/pubs\/surv-manual\/chpt14-rubella.html"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Macey JF, Tam T, Lipskie T, Tipples G, Eisbrenner T. Rubella elimination, the Canadian experience. J Infect Dis. 2011;204(Suppl 2):S585-92.","DOI":"10.1093\/infdis\/jir406"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Saboui M, Hiebert J, Squires SG, Guay M, Barcellos P, Thom A, Li YA. Re-verifying the elimination of measles, rubella and congenital rubella syndrome in Canada, 2016-2020. Can Commun Dis Rep. 2021;47(11):476-8.","DOI":"10.14745\/ccdr.v47i11a06"},{"key":"ref22","unstructured":"Government of Canada. Elimination of Measles Rubella and Congenital Rubella Syndrome in Canada Documentation and Verification Report: Executive Summary. Ottawa: Government of Canada. [Accessed 20 March 2024]. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/immunization\/vaccine-preventable-diseases\/elimination-measles-rubella-congenital-rubella-syndrome-canada-documentation-verification-report.html"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33(7):1870-4.","DOI":"10.1093\/molbev\/msw054"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Zhu Z, Cui A, Zhang Y, Mao N, Liu Y, Liu L, et al. Transmission dynamics of the rubella virus circulating in china during 2010\u20132019: 2 lineage switches between genotypes 1e and 2b. Clin Infect Dis. 2021;73(7):1157-64.","DOI":"10.1093\/cid\/ciab339"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Mori Y, Miyoshi M, Kikuchi M, Sekine M, Umezawa M, Saikusa M, et al. Molecular epidemiology of rubella virus strains detected around the time of the 2012-2013 epidemic in Japan. Front Microbiol. 2017;8:1513.","DOI":"10.3389\/fmicb.2017.01513"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Tushabe P, Bwogi J, Abernathy E, Birungi M, Eliku JP, Seguya R, et al. Descriptive epidemiology of rubella disease and associated virus strains in Uganda. J Med Virol. 2020;92(3):279-87.","DOI":"10.1002\/jmv.25604"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Icenogle JP, Frey TK, Abernathy E, Reef SE, Schnurr D, Stewart JA. Genetic analysis of rubella viruses found in the United States between 1966 and 2004: evidence that indigenous rubella viruses have been eliminated. Clin Infect Dis. 2006;43(suppl 3):S133-40.","DOI":"10.1086\/505945"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Kanbayashi D, Kurata T, Nishino Y, Orii F, Takii Y, Kinoshita M, et al. Rubella virus genotype 1e in travelers returning to Japan from Indonesia, 2017. Emerg Infect Dis. 2018;24(9):1763-5.","DOI":"10.3201\/eid2409.180621"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Abernathy ES, H\u00fcbschen JM, Muller CP, Jin L, Brown D, Komase K, et al. Status of global virologic surveillance for rubella viruses. J Infect Dis. 2011;204(suppl 1):S524-32.","DOI":"10.1093\/infdis\/jir099"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Reef SE, Redd SB, Abernathy E, Kutty P, Icenogle JP. Evidence used to support the achievement and maintenance of elimination of rubella and congenital rubella syndrome in the United States. J Infect Dis. 2011;204(suppl 2):S593-7.","DOI":"10.1093\/infdis\/jir420"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Zimmerman LA, Knapp JK, Antoni S, Grant GB, Reef SE. Progress toward rubella and congenital rubella syndrome control and elimination\u2014worldwide, 2012-2020. MMWR Morb Mortal Wkly Rep. 2022;71(6):196-201.","DOI":"10.15585\/mmwr.mm7106a2"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Perelygina L, Buchbinder D, Dorsey MJ, Eloit M, Hauck F, Hautala T, et al. Outcomes for nitazoxanide treatment in a case series of patients with primary immunodeficiencies and rubella virus-associated granuloma. J Clin Immunol. 2019;39(1):112-7.","DOI":"10.1007\/s10875-019-0589-0"},{"key":"ref33","unstructured":"Pan American Health Organization. Guidance for testing of measles and rubella in the laboratory network of the Region of Americas. Washington DC: PAHO; 2019. [Accessed 20 March 2024]. Available from: https:\/\/iris.paho.org\/bitstream\/handle\/10665.2\/34932\/9789275119976_eng.pdf"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Knapp JK, Mariano KM, Pastore R, Grabovac V, Takashima Y, Alexander JP, Jr., et al. Progress toward rubella elimination\u2013Western Pacific Region, 2000-2019. MMWR Morb Mortal Wkly Rep. 2020;69(24):744-50.","DOI":"10.15585\/mmwr.mm6924a4"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Vaidya SR, Kasibhatla SM, Kamble MB, Munivenkatappa A, Kumbhar NS, Jayaswamy MM, et al. Genetic and antigenic characterization of wild type rubella viruses isolated from India. Vaccine. 2021;39(6):876-81.","DOI":"10.1016\/j.vaccine.2020.12.063"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Sepp\u00e4l\u00e4 EM, L\u00f3pez-Perea N, Torres de Mier MV, Echevarr\u00eda JE, Fern\u00e1ndez-Garc\u00eda A, Masa-Calles J. Last cases of rubella and congenital rubella syndrome in Spain, 1997-2016: the success of a vaccination program. Vaccine. 2019;37(1):169-75.","DOI":"10.1016\/j.vaccine.2018.11.017"}],"container-title":["Revista Panamericana de Salud P\u00fablica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iris.paho.org\/bitstream\/handle\/10665.2\/62402\/v48e1042024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T11:44:02Z","timestamp":1734349442000},"score":1,"resource":{"primary":{"URL":"https:\/\/iris.paho.org\/handle\/10665.2\/62402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,16]]},"references-count":36,"alternative-id":["RPSP.2024.104"],"URL":"https:\/\/doi.org\/10.26633\/rpsp.2024.104","relation":{},"ISSN":["1020-4989","1680-5348"],"issn-type":[{"value":"1020-4989","type":"print"},{"value":"1680-5348","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,16]]}}}